New Drugs, FDC, Clinical Trial – Notifications

Last Updated on January 6, 2024 by The Health Master

Download New Drugs, FDC, Clinical Trial – Notifications

Gazette of India

The Govt. of India issues notifications from time to time, which are published by the Department of Publication and are printed by the Government of India Printing Presses regularly.

We have provided some of the notifications relevant to the above-said topic, Click on the below links for more information:

2023

GSR No. 364(E) dt 11-05-2023 Draft New Drugs and Clinical Trials (Amendment) Rules, 2022

GSR 175(E) dt 09-03-2023 New Drug and Clinical Trial (Amendment) Rules 2023 – additional testing methods to assess safety & efficacy of iPSC included

2022

GSR No. 835(E) dt 22-11-2022 Draft notification – Specific requirements on non-clinical studies – New Drugs and Clinical Trials Rules, 2022

GSR 778(E) dt 14-10-2022 New Drugs and Clinical Trials (Third Amendment) Rules, 2022

S.O. 553(E) dt 09-02-2022 Stockpiling of new drug under phase 3 of clinical trial New Drugs and Clinical Trials Rules 2019

GSR No. 32(E) dt 21-01-2022 Draft notification -Insertion of Proviso for deemed approvals in Rule 8 under New Drugs and Clinical Trials Rules 2019

GSR No. 21(E) dt 18-01-2022 – Designated Registration Authority in Form CT-3 -New Drugs and Clinical Trials (2nd Amendment) Rules, 2022

GSR No. 14(E) dt 13-01-2022 – Final notification Rule 2 – New Drugs and Clinical Trials (Amendments) Rules 2022

2021

GSR 767(E) dt 27-10-2021 Draft – to amend rule 2 to substitute cell or stem cell derived product under New Drugs and Clinical Trial Rules 2019

GSR-767E-dt-27-10-2021-Draft-to-amend-rule-2-to-substitute-cell-or-stem-cell-derived-product-under-NDCTR-2019

GSR 605(E) dt 31-08-2021 Standalone Bioanalytica New Drugs and Clinical Trials (Amendment) Rules 2021

GSR No. 524 (E) dt 02-08-2021 Draft – New Drugs and Clinical Trial (Amendment) Rules 2021

GSR-No.-524-dt-02-08-2021-DRaft-New-Drugs-and-Clinical-TrialAmendment-Rules-2021

GSR 99(E) dt 05-02-2021 -Draft notification For inclusion of provisions related to the registration of stand alone bio analytical laboratories in the NDCT Rules, 2019

2020

GSR No. 354(E) dt 05-06-2020 – Regarding New Drugs and trial (Amendment) Rules 2020 draft

2019

GSR 227 (E) dt 19-03-2019 – New Drugs and Clinical Trials Rules 2019

2018

G.S.R-360-E-dt.-10-04-2018-New-Drug-word-Patent-and-proprietary-substituted-as-word-Drug

2011

GSR 45(E) dt 24-01-2011 – Vaccines and Recombinant are new drugs – Drugs and Cosmetics (1st Amendment) Rules 2011

GSR-45E-dt-24-01-2011-Vaccines-and-Recombinant-are-new-drugs-Drugs-and-Cosmetics-1st-Amendment-Rules-2011

2009

GSR 738(E) dt 09-10-2009 Amendment in the notification number G.S.R. 578(E), 23rd July, 1983 Substitutes FDC of Corticosteroid with any other drug for internal use

GSR-738E-dt-09-10-2009-Amendment-in-the-notification-number-G.S.R.-578E-23rd-July-1983-Substitutes-FDC-of-Corticosteroid-with-any-other-drug-for-internal-use


Banned Drugs

Blood Bank / Centre

Cosmetics

COTPA

DPCO / NPPA

Drug Rules

Drugs Act

DMROA

EC Act

General

Homoeopathic

Hospital – RMI

Medical Devices

NDPS Act

New Drugs

Testing Laboratories

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news